- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04825483
Effects of a Weight Loss Program in People With Hip Osteoarthritis (ECHO)
Effects of a Weight Loss Program in People With Hip Osteoarthritis: a Randomised Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Clinical guidelines recommend exercise as the core treatment for symptoms, but provide conflicting recommendations about weight loss for people with hip OA. Irrefutable health benefits are associated with weight loss for those with overweight or obesity, but it remains uncertain whether weight loss in addition to exercise and regular physical activity is superior to exercise alone for hip OA symptoms.
This study is a randomized controlled trial for which the aim is to determine whether a weight loss and exercise program improves hip pain more than an exercise program alone at 6 months among people with hip OA who have overweight or obesity.
A total of 100 people with hip osteoarthritis and overweight or obesity will be recruited from the community. Participants will be assessed for eligibility, including review of a hip x-ray. They will be enrolled into the study following informed consent and completion of baseline questionnaires and laboratory-based measures. Each participant will be randomly allocated to receive either: a) weight loss plus exercise program or; b) exercise program alone, over 6 months.
The randomisation schedule will be prepared by a biostatistician (permuted block sizes 2 to 6) stratified by site and sex. Participants allocated to the exercise group will be randomly allocated to a physiotherapist. Participants allocated to the exercise plus weight loss group will be randomly allocated to one of the same physiotherapists as the exercise group, and to a dietitian. The schedule will be stored on a password-protected platform at the University of Melbourne and maintained by a researcher not involved in either participant recruitment or administration of outcome measures. Group allocation will be revealed after completion of baseline measures and randomisation.
Dietitians will complete training in best-practice OA management (half day workshop led by investigators), motivational interviewing skills (2-day training course), weight management (the ketogenic very low calorie diet) and trial procedures. Physiotherapists will be trained in trial procedures, best practice OA management, strengthening and physical activity program, behaviour change techniques to promote adherence and resources for use in the program.
Study participants in both groups will attend 5 individual physiotherapy consultations via video-conference over 6 months and will undertake a home-based lower limb muscle strengthening exercise and physical activity program. Those in the weight loss and exercise group will also undertake a ketogenic very low calorie diet (VLCD), which has been demonstrated as a safe and effective means of achieving rapid weight loss in the adult population with overweight/obesity. They will receive meal replacements (maximum 2 per day) for up to 6 months as well as educational resources.
A biostatistician will analyse blinded data. The statistical method will be outlined in a Statistical Analysis Plan.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kim Bennell, PhD
- Phone Number: +61 3 83444135
- Email: k.bennell@unimelb.edu.au
Study Contact Backup
- Name: Libby Spiers, BPhysio
- Phone Number: +61 3 90353886
- Email: libby.spiers@unimelb.edu.au
Study Locations
-
-
Victoria
-
Carlton, Victoria, Australia, 3010
- University of Melbourne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- American College of Rheumatology classification criteria with pain in the groin or hip region on most days of the past month and femoral or acetabular osteophytes and joint space narrowing (superior, axial and/ or medial) on x-ray;
- aged 50 years or older;
- report history of hip pain ≥ 3months;
- report an average pain score of at least 4 on an 11-point numeric rating scale (anchored at 0=no pain, 10=worst pain imaginable) over the previous week;
- access to a device with internet connection;
- have a BMI >27 kg/m2;
- willing and able give informed consent and participate fully in the interventions and assessment procedures;
- have ability to weigh themselves (e.g. access to scales);
- pass the Exercise and Sports Science Australia stage 1 adult pre-exercise screening system or obtain general practitioner clearance for participation in the study.
Exclusion Criteria:
- weight >150 kgs (due to the added complexities of additional nutritional requirements for individuals above this weight);
- inability to speak and read English;
- on waiting list for/planning back/lower limb surgery or bariatric surgery in next 12 months;
- previous arthroplasty on affected hip;
- recent hip surgery on affected hip (past 6 months);
- self-reported inflammatory arthritis (e.g. rheumatoid arthritis);
- weight loss of > 2 kg over the previous 3 months;
already actively trying to lose weight by any of the following mechanisms:
- using meal replacements for weight loss
- being a member of a commercial weight loss program (e.g. weight watchers)
- receiving support from another health care professional for weight loss
- using any drugs prescribed to aid in weight loss
- using structured meal programs for weight loss such as 'Lite n' Easy'
unable to undertake ketogenic VLCD without closer medical supervision including self-reported:
- diagnosis of Type 1 diabetes
- Type 2 diabetes requiring insulin or other medication apart from metformin
- warfarin use
- stroke or cardiac event in previous 6 months
- unstable cardiovascular condition
- fluid intake restriction
- renal (kidney) problems (unless clearance is obtained from GP, including GP confirmation that estimated glomerular filtration rate >30 mL/min/1.73m2)
- any neurological condition affecting lower limbs;
- pregnancy or planned pregnancy
- vegan dietary requirements due to complexity of delivering a nutritionally complete diet within the ketogenic diet regime.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Weight loss and exercise
In addition to the physiotherapist-prescribed exercise program, participants in the weight loss and exercise group will also undergo six consultations with a dietitian.
They will undergo a ketogenic very low-calorie diet (VLCD) including meal replacements, with an intensive weight loss phase and weight maintenance phase.
The exercise component will be the same as that provided for the exercise only comparator.
All dietitian and physiotherapy consultations will be delivered online by video-conference platform.
|
Participants will receive resources to support the weight loss program including a recipe book, activities book and "how-to guide".
The diet program comprises two phases: 1) intensive weight loss through a ketogenic Very Low Calorie Diet (VLCD), including meal replacements for two meals/day, and 2) transition from ketogenic VLCD onto a longer-term eating plan for weight maintenance.
Meal replacements will be provided free of charge for up to 6 months.
Participants will be encouraged to lose at least 10% body weight.
Participants will receive resources to facilitate the physiotherapy management plan, including information about the video-conference platform, osteoarthritis information, an exercise plan/log book and a booklet of possible exercises. The physiotherapist consultations include a structured, progressive exercise and physical activity plan. Participants will be given exercise resistance bands and a ankle weight for home exercises. Physiotherapists will choose from a list of exercises, aiming to prescribe 5-6 at once. Intensity is determined using a modified Rating of Perceived Exertion (RPE) scale, where it should feel "hard" to "very hard" to perform a full set of each exercises. Participants are encouraged to complete exercises three times per week. Physiotherapists encourage the participant to increase their general and incidental levels of physical/aerobic activity based on their individual needs and goals, as well as their current level of activity. |
Active Comparator: Exercise only
Participants will undergo five consultations (30-45 minutes) with a physiotherapist over 6 months for prescription of a home-based strengthening exercise program and physical activity plan (to be conducted independently at home), as well as OA education.
All consultations will be conducted remotely via video-conference.
|
Participants will receive resources to facilitate the physiotherapy management plan, including information about the video-conference platform, osteoarthritis information, an exercise plan/log book and a booklet of possible exercises. The physiotherapist consultations include a structured, progressive exercise and physical activity plan. Participants will be given exercise resistance bands and a ankle weight for home exercises. Physiotherapists will choose from a list of exercises, aiming to prescribe 5-6 at once. Intensity is determined using a modified Rating of Perceived Exertion (RPE) scale, where it should feel "hard" to "very hard" to perform a full set of each exercises. Participants are encouraged to complete exercises three times per week. Physiotherapists encourage the participant to increase their general and incidental levels of physical/aerobic activity based on their individual needs and goals, as well as their current level of activity. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Severity of hip pain
Time Frame: Change between baseline and 6 months post-randomisation
|
Scored on an 11-point Numeric Rating Scale for average hip pain in the last week.
Ranges from 0 to 10; where 0=no pain and 10=worst pain possible.
|
Change between baseline and 6 months post-randomisation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Severity of hip pain
Time Frame: Change between baseline and 12 months post-randomisation
|
Scored on an 11-point Numeric Rating Scale for average hip pain in the last week.
Ranges from 0 to 10; where 0=no pain and 10=worst pain possible.
|
Change between baseline and 12 months post-randomisation
|
Body weight
Time Frame: Change between baseline and 6 months post-randomisation
|
Measured on home scales and self-reported in kilograms.
The percentage of body weight change (baseline-follow up/baseline x100%) will be calculated .
|
Change between baseline and 6 months post-randomisation
|
Body weight
Time Frame: Change between baseline and 12 months post-randomisation
|
Measured on home scales and self-reported in kilograms.
The percentage of body weight change (baseline-follow up/baseline x100%) will be calculated .
|
Change between baseline and 12 months post-randomisation
|
Body Mass Index (BMI)
Time Frame: Change between baseline and 6 months post-randomisation
|
Calculated from height and weight, in Kg/m2
|
Change between baseline and 6 months post-randomisation
|
Body Mass Index (BMI)
Time Frame: Change between baseline and 12 months post-randomisation
|
Calculated from height and weight, in Kg/m2
|
Change between baseline and 12 months post-randomisation
|
Total body fat mass
Time Frame: Change between baseline and 6 months post-randomisation
|
Measured using dual energy x-ray absorptiometry and reported in grams and % of total body mass
|
Change between baseline and 6 months post-randomisation
|
Hip pain
Time Frame: 6 months post-randomisation
|
Proportion of participants who meet or exceed the minimal clinical important difference in Numerical Rating Scale for pain (1.8 units).
Expressed as percentage relative to number of participants allocated to each group.
|
6 months post-randomisation
|
Hip pain
Time Frame: 12 months post-randomisation
|
Proportion of participants who meet or exceed the minimal clinical important difference in Numerical Rating Scale for pain (1.8 units).
Expressed as percentage relative to number of participants allocated to each group.
|
12 months post-randomisation
|
Hip Osteoarthritis Outcome Scale (HOOS) Pain Subscale
Time Frame: Change between baseline and 6 months post-randomisation
|
Scored using 10 questions regarding hip pain in the last week, with Likert response options ranging from no pain to extreme pain.
Ranges from 0 to 20 and normalised to 0 - 100 scale.
Higher scores indicate less pain.
|
Change between baseline and 6 months post-randomisation
|
Hip Osteoarthritis Outcome Scale (HOOS) Pain Subscale
Time Frame: Change between baseline and 12 months post-randomisation
|
Scored using 10 questions regarding hip pain in the last week, with Likert response options ranging from no pain to extreme pain.
Ranges from 0 to 20 and normalised to 0 - 100 scale.
Higher scores indicate less pain.
|
Change between baseline and 12 months post-randomisation
|
Hip Osteoarthritis Outcome Scale (HOOS) Activities of daily living subscale
Time Frame: Change between baseline and 6 months post-randomisation
|
Scored using 17 questions regarding hip function in the last week, with Likert response options ranging from no dysfunction to extreme dysfunction.
Ranges from 0 to 68 and normalised to 0 - 100 scale.
Higher scores indicate less dysfunction.
|
Change between baseline and 6 months post-randomisation
|
Hip Osteoarthritis Outcome Scale (HOOS) Activities of daily living subscale
Time Frame: Change between baseline and 12 months post-randomisation
|
Scored using 17 questions regarding hip function in the last week, with Likert response options ranging from no dysfunction to extreme dysfunction.
Ranges from 0 to 68 and normalised to 0 - 100 scale.
Higher scores indicate less dysfunction.
|
Change between baseline and 12 months post-randomisation
|
Hip Osteoarthritis Outcome Scale (HOOS) Quality of Life Subscale
Time Frame: Change between baseline and 6 months post-randomisation
|
Scored using 4 questions regarding quality of life in the last week, with Likert response options ranging from none to extreme.
Ranges from 0 to 16 and normalised to 0 - 100 scale.
Higher scores indicate better quality of life.
|
Change between baseline and 6 months post-randomisation
|
Hip Osteoarthritis Outcome Scale (HOOS) Quality of Life Subscale
Time Frame: Change between baseline and 12 months post-randomisation
|
Scored using 4 questions regarding quality of life in the last week, with Likert response options ranging from none to extreme.
Ranges from 0 to 16 and normalised to 0 - 100 scale.
Higher scores indicate better quality of life.
|
Change between baseline and 12 months post-randomisation
|
Quality of life (AQoL-8D)
Time Frame: Change between baseline and 6 months post-randomisation
|
Scored from 35 questions regarding health-related quality of life in the last week.
Ranges from -0.04 to 1.00; higher scores indicate better quality of life.
|
Change between baseline and 6 months post-randomisation
|
Quality of life (AQoL-8D)
Time Frame: Change between baseline and 12 months post-randomisation
|
Scored from 35 questions regarding health-related quality of life in the last week.
Ranges from -0.04 to 1.00; higher scores indicate better quality of life.
|
Change between baseline and 12 months post-randomisation
|
Global rating of change in physical activity
Time Frame: 6 months post-randomisation
|
Scored using a 7-point global rating of change Likert scale with response options ranging from "much less" to "much more" when compared to baseline.
|
6 months post-randomisation
|
Global rating of change in physical activity
Time Frame: 12 months post-randomisation
|
Scored using a 7-point global rating of change Likert scale with response options ranging from "much less" to "much more" when compared to baseline.
|
12 months post-randomisation
|
Global rating of overall change in hip problem
Time Frame: 6 months post-randomisation
|
Scored using a 7-point global rating of change Likert scale with response options ranging from "much worse" to "much better" when compared to baseline.
|
6 months post-randomisation
|
Global rating of overall change in hip problem
Time Frame: 12 months post-randomisation
|
Scored using a 7-point global rating of change Likert scale with response options ranging from "much worse" to "much better" when compared to baseline.
|
12 months post-randomisation
|
Visceral fat mass
Time Frame: Change between baseline and 6 months post-randomisation
|
Measured using dual energy x-ray absorptiometry and reported in grams and % of total body mass
|
Change between baseline and 6 months post-randomisation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kim Bennell, PhD, University of Melbourne
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20516
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Osteoarthritis
-
Istituto Ortopedico RizzoliRecruiting
-
University of California, San FranciscoStanford University; Robert Wood Johnson FoundationCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
-
CHU de ReimsCompleted
-
Royan InstituteCompletedHip OsteoarthritisIran, Islamic Republic of
-
Daiichi Sankyo, Inc.TerminatedSymptomatic Hip OsteoarthritisFrance
-
University of VermontCompletedOsteoarthritis of Knee | Osteoarthritis Of HipUnited States
-
Oxford University Hospitals NHS TrustCompletedKnee Osteoarthritis | Hip Osteoarthritis | Knee Arthroplasty | Hip ArthroplastyUnited Kingdom
-
University of ArkansasCompletedKnee Osteoarthritis | Hip Osteoarthritis | Knee Arthritis | Hip ArthritisUnited States
-
Johan KarrholmCompletedPrimary Osteoarthritis of Hip Nos | Secondary Osteoarthritis of Hip
-
Lawson Health Research InstituteCompletedHip Osteoarthritis | Hip ArthroplastyCanada
Clinical Trials on Weight loss
-
University of VermontUniversity of Vermont Medical CenterCompletedBreast Cancer | Overweight | PostmenopausalUnited States
-
University of PittsburghCompleted
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Completed
-
VA Office of Research and DevelopmentTerminatedOverweight | Obstructive Sleep ApneaUnited States
-
Boston Children's HospitalUniversity of Alabama at Birmingham; Indiana University; Baylor University; Framingham...Terminated
-
University of TennesseeCompleted
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Maryland Cigarette Restitution FundCompletedKidney Cancer | Breast Cancer | Rectal Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Melanoma (Skin) | Gallbladder CancerUnited States
-
University of Alabama at BirminghamCompletedCancer | Weight LossUnited States